|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 371 - 380 of 441:
New Treatment Option for Epilepsy Patients With One of the Most Debilitating Seizure Types
The FDA approved UCB's leading anti-epileptic drug Keppra (levetiracetam) tablets and oral solution as adjunctive therapy in the treatment of primary ...
FDA approves Tykerb for advanced or metastatic breast cancer
GlaxoSmithKline said that the United States Food and Drug Administration (FDA) approved TYKERB (lapatinib), in combination with Xeloda (capecitabine),...
FDA Extends Marketing Exclusivity for LEVAQUIN
The U.S. Food and Drug Administration (FDA) has granted LEVAQUIN (levofloxacin) an additional six months of marketing exclusivity, known as "pediatric...
MHR Unveils FDA Approved Rezultz LaserComb, a New In-Home Drug-Free Treatment
Medical Hair Restoration's (MHR) new Rezultz LaserComb is poised to revolutionize the hair growth industry as the only FDA-approved, drug-free alterna...
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Pharmaceuticals has received tentative approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA)...
Neose Receives FDA Clearance to Commence U.S. Clinical Trials for NE-180
Neose Technologies said that it has received clearance from the United States Food and Drug Administration (FDA) to commence clinical trials for NE-18...
SAP and TechniData Provide First Integrated REACH Solution to Help Chemical Companies Comply With New EU Regulations
Further demonstrating continued investment in industry-specific technology solutions that enable companies to meet the challenge of regulatory complia...
FDA Approves GSK Late-Stage Breast Cancer Drug Tykerb
FDA has approved GlaxoSmithKline's breast cancer drug Tykerb in combination with Roche's chemotherapy drug Xeloda as a treatment for women with late-s...
Advanced Life Sciences Announces Cethromycin Granted FDA Orphan Drug Designation for Anthrax
Advanced Life Sciences Holdings announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to cethromycin...
FDA Requests Label Change for All Sleep Disorder Drug Products
The U.S. Food and Drug Administration (FDA) has requested that all manufacturers of sedative-hypnotic drug products, a class of drugs used to induce a... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2008 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |